Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics. [PDF]
Evans AJ, Li YL.
europepmc +1 more source
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia. [PDF]
Yohn SE+3 more
europepmc +1 more source
Xanomeline-trospium (CobenfyTM) for Schizophrenia: A Review of the Literature. [PDF]
Smith CM+6 more
europepmc +1 more source
Muscarinic acetylcholine type 1 receptor antagonism activates TRPM3 to augment mitochondrial function and drive axonal repair in adult sensory neurons. [PDF]
Chauhan S+6 more
europepmc +1 more source
Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM). [PDF]
Engers JL+17 more
europepmc +1 more source
Structural determinants of M2R involved in inhibition by Sigma-1R. [PDF]
Liu C+4 more
europepmc +1 more source
Cholinergic modulation in the vertebrate auditory pathway. [PDF]
Zhang C, Burger RM.
europepmc +1 more source
GPCR-BSD: a database of binding sites of human G-protein coupled receptors under diverse states. [PDF]
Liu F+7 more
europepmc +1 more source
Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and in vivo perspectives. [PDF]
Kim MJ, Ibrahim MM, Jablonski MM.
europepmc +1 more source
Acetylcholine regulates the melanogenesis of retinal pigment epithelia cells via a cAMP-dependent pathway: A non-neuronal function of cholinergic system in retina. [PDF]
Kong I+6 more
europepmc +1 more source